To reduce the risk of ovarian cancer, prophylactic bilateral adnexectomy is strongly recommended for women with BRCA1 mutations before the age of 40 and can be deferred until the age of 45 for women with BRCA2 mutations [69]. This evidence concerns the gene BRCA1 and ovarian carcinoma.